BrightSpring Health Services spent the year rolling out more limited distribution drugs and integrating new home health locations, while quarterly reports showed revenue and net margin on the Q3 2026 statement both higher than a year earlier. Holding BrightSpring Health Services over the past year would have returned 115.8%, including dividends. If you were deciding back on 11 November 2025, what would you have needed to believe about this business for that outcome to appear reasonable? The...
BrightSpring Health Services is one of the country's largest providers of specialized care for seniors and others with chronic or "complex" health problems.
IPO Stock Of The Week BrightSpring is approaching a new buy point despite heavy market losses over this past week.
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Detailed price information for Mckesson Corp (MCK-N) from The Globe and Mail including charting and trades.
BrightSpring Health Services (BTSG) is rated Hold as robust revenue and EBITDA growth are balanced by margin pressures and valuation concerns.
Detailed price information for Cullinan Therapeutics Inc (CGEM-Q) from The Globe and Mail including charting and trades.
Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 4.8% in the afternoon session after BMO Capital analyst Sean Dodge reiterated an Outperform rating and a $70 price target on the company, StreetInsider reported.
Detailed price information for Brightspring Health Services Inc (BTSG-Q) from The Globe and Mail including charting and trades.
LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2026 financial results on Friday, October 30, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on t
BrightSpring Health Services (NASDAQ:BTSG) outlined its growth strategy across pharmacy and provider services at the Bernstein healthcare services conference, emphasizing specialty pharmacy expansion, home health acquisitions, technology investments and opportunities to integrate services for comple
BrightSpring Health Services (BTSG) is back on investor radar after Carillon Eagle Small Cap Growth Fund highlighted the healthcare provider in its second quarter 2026 letter, citing revenue and adjusted EBITDA ahead of IPO expectations. Despite the upbeat fund commentary, BrightSpring Health Services has hit a softer patch on the screen, with the share price at US$56.55 after a 1-day share price return of 1.24% but a 90-day share price return that has declined 16.36%. The year-to-date share...
Momentum stocks Centene, BrightSpring Health Services and Delek US show strong annual gains despite recent weekly pullbacks.
Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. The letter can be downloaded here. Small-cap stocks rallied broadly in the second quarter, with the Russell 2000 Growth Index (+25.71%) outpacing Value +17.24%). Information Technology (+46.79%) led all sectors, supported by solid gains […]
BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.
Detailed price information for Comfort Systems USA (FIX-N) from The Globe and Mail including charting and trades.
BrightSpring Health's premium 34.38x FY1 P/E is justified by strong EBITDA growth and a forward PEG of 0.73x. Find out why BTSG stock is a buy.
This is the newest page. Registered accounts read further back.